TrialDigestive diseases and sciences2008

Interferon beta 1a versus interferon beta 1a plus ribavirin for the treatment of chronic hepatitis C in Chinese patients: a randomized, placebo-controlled trial.

Qunying Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.